Real-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Yan Xiong, MS
Advertisement
Articles by Yan Xiong, MS
Advertisement
Latest Updated Articles
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and CostsPublished: April 18th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
2
From Stigma to Breakthrough: Psychedelic Medicine
3
Pharmacists Can Drive Equitable Diagnostics Access, Improve Antimicrobial Resistance Stewardship
4
Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations
5
